Please wait while your page loads ...
From Thursday, September 24, 2020 until Friday, September 25, 2020 Save to calendar
The FARA 2020 Biomarker & Clinical Endpoint Meeting will be held virtually on September 24th and 25th, 2020.
The purpose of the meeting will be to review the state of biomarker and novel endpoint development for Friedreich's ataxia. The focus will be on pharmacodynamic and monitoring biomarkers both for translational and clinical applications, as well as clinical outcome assessments. FARA’s goal is to have a toolbox of biomarkers and outcome assessments that can be used in various settings and for diverse treatment approaches. Highly innovative biomarkers or outcome assessments at early stages of development will be considered, as well as research in later or validation stages.
Meeting sessions will include: Monitoring biomarkers, Pharmacodynamic biomarkers and Clinical Outcome Assessments and will be held as scheduled:
Session 1: September 24th 8am-10am EDT
Session 2: September 24th 4pm- 7pm EDT
Session 3: September 25th 8am-10am EDT
Session 4: September 25th 4pm-7pm EDT
Oral presentations will be selected among abstract submissions and will consist of 10-minute talks followed by 5 minutes of Q&A. Each session will conclude with a moderated panel discussion on challenging questions in the field.
Meeting registration is free of charge.